57P - Mucin 1 (MUC1) expression in patients (pts) with early stage non-small cell lung cancer (NSCLC): relationship between immunohistochemistry (IHC) in...
|Date||28 March 2014|
|Session||Lunch and poster display session|
|Topics|| Non-Small-Cell Lung Cancer, Early Stage
|Citation||Journal of Thoracic Oncology (2014) 9 (Supplement 9): S7-S52. 10.1097/JTO.0000000000000131|
P.L.R. Mitchell1, K. Asadi2, T. John1, C. Murone3, S. Knight4
MUC1, a glycoprotein highly expressed in many malignancies, is being explored as an antigen for immunotherapy. Although MUC1 expression on IHC is very frequent In NSCLC (Mitchell et al. Proc ASCO 2013, abs 3011) and circulating sMUC1 may be elevated, the relationship has been poorly studied. This study explored the relationship between MUC1 IHC and plasma sMUC1 in patients undergoing lobectomy or pneumonectomy for NSCLC.